TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive CCOP Success Acknowledged, Recompetition Plans Being Made; Cancer Control May Be Added To RFA April 11, 1986
TCL Archive In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos May 9, 1997